A Novel Differential Predict Model Based on Matrix-Assisted Laser Ionization Time-of-Flight Mass Spectrometry and Serum Ferritin for Acute Graft-versus-Host Disease

Table 2

Demographic and clinical characteristics of patients with and without acute GVHD.

Case	Age	Recipient; gender	Doner; gender	Underlying; disease	Donor; type	Pretreatment	Clinically affected; aGVHD organ	aGVHD; grade
1	48	M	F	AML	Related	BU + CY	Skin, mouth, gastrointestinal tract	IV
2	36	M	F	AML	Related	BU + CY		0
3	25	M	M	AML	Related	BU + CY		0
4	47	M	M	AML	Related	BU + CY	Skin, mouth	0
5	53	F	F	CML	Related	Flud + BU	Gastrointestinal tract	III
6	14	M	M	ALL	Related	TBI + CY + ATG		0
7	31	F	F	AML	Unrelated	BU + CY	Skin	I
8	15	M	M	AML	Related	BU + CY + ATG	Skin, liver	II
9	40	M	M	MDS	Related	BU + CY + ATG	Skin, mouth, gastrointestinal tract	IV
10	22	M	M	ALL	Related	TBI + CY + ATG	Skin, mouth, liver, gastrointestinal tract	III
11	22	M	M	MDS	Unrelated	BU + CY + ATG	Skin, mouth, gastrointestinal tract	IV
12	44	F	F	AML	Unrelated	BU + CY + ATG	Gastrointestinal tract	II
13	28	M	M	ALL	Unrelated	TBI + CY + ATG		0
14	28	M	M	ALL	Related	TBI + CY		0
16	47	F	F	CML	Related	BU + CY	Skin, liver, gastrointestinal tract	II
17	43	M	M	MDS	Related	BU + CY + ATG	Gastrointestinal tract	II
18	44	M	F	AML	Related	BU + CY	Liver, gastrointestinal tract	III
19	49	F	F	ALL	Unrelated	BU + CY + ATG	Gastrointestinal tract	II
22	15	M	M	ALL	Unrelated	BU + CY + ATG	Skin	I
30	23	M	M	ALL	Related	Flud + BU	Gastrointestinal tract	II
33	16	M	F	MDS	Related	BU + CY + ATG	Gastrointestinal tract	I
36	43	M	M	AML	Unrelated	BU + CY + ATG	Skin	I
39	27	F	F	CML	Unrelated	BU + CY	Skin, mouth	I
40	45	M	M	MDS	Related	BU + CY	Skin	I

M: male; F: female; AML: acute myelogenous leukemia; CML: chronic myelogenous leukemia; MDS: myelodysplastic syndrome; ALL: acute lymophoblastic leukemia; TBI: total body irradiation; BU: busulfan; CY: cyclophosphamide; Flud: fludarabine; ATG: rabbit antithymocyte globulin.